| Unc-13 Homolog B (Munc13-2) |
|---|
| Protein Name | Munc13-2 |
| Gene | UNC13B |
| UniProt ID | Q9Y5S4 |
| PDB ID | 5W5W, 6CY4 |
| Molecular Weight | 190 kDa (1737 amino acids) |
| Localization | Presynaptic active zone, synaptic vesicles |
| Protein Family | Munc13 family |
| Tissue Specificity | Brain (cortex, hippocampus), endocrine cells |
Munc13-2 (UNC13B) is a homolog of Munc13-1 with overlapping and distinct functions in the presynaptic active zone. It plays critical roles in synaptic vesicle priming, neurotransmitter release, and short-term synaptic plasticity. Like its paralog Munc13-1, Munc13-2 is essential for synaptic transmission and is implicated in neurodegenerative diseases including Alzheimer's disease, ALS, and epilepsy.
Munc13-2 exists in multiple isoforms with distinct domain compositions, allowing for regulated localization and function at different synaptic compartments.
Munc13-2 contains several distinct domains:
- C1 Domain: Diacylglycerol (DAG) binding domain that mediates phorbol ester responsiveness
- C2A Domain: Calcium/phospholipid binding domain
- MUN Domain (300-1100 aa): Core catalytic domain that mediates vesicle priming
- C2B Domain: Additional calcium-dependent membrane interaction
- Full-length Munc13-2: Contains all domains, similar to Munc13-1
- Munc13-2B: Lacks C1 domain, alternative splicing variant
- Munc13-2C: Brain-specific isoform with unique N-terminus
Munc13-2 performs several critical synaptic functions:
- Converts fusion-competent docked vesicles into readily releasable pool (RRP)
- Interacts with Munc18-1 and syntaxin-1 to open SNARE complex assembly
- Determines the size and composition of the RRP
- Regulates spontaneous release (mini release)
- Regulates release probability
- Modulates facilitation and depression
- Couples calcium influx to vesicle release
- Recruits other active zone proteins
- Forms scaffolding complexes with RIM, ELKS, and Bassoon
- Maintains synaptic vesicle pools
Munc13-2 operates through several mechanisms:
- Munc13-2 binds to closed syntaxin-1 via its MUN domain
- This releases syntaxin-1 from Munc18-1 inhibition
- SNARE complex assembly can proceed
- Vesicles become fusion-competent
- Calcium influx triggers rapid fusion
- Phorbol esters: Activate via C1 domain binding
- Calmodulin: Calcium-dependent regulation via C2 domains
- Phosphorylation: PKA and other kinases modulate function
- Altered Munc13-2 expression in AD brains
- May contribute to synaptic dysfunction
- Connected to amyloid-beta effects on presynaptic terminals
- Synaptic vesicle priming deficits precede memory loss
- UNC13B variants associated with ALS risk
- Alters synaptic transmission in motor neurons
- May affect excitotoxicity mechanisms
- Connection to TDP-43 pathology
- Munc13-2 variants may influence seizure threshold
- Altered vesicle priming affects inhibitory/excitatory balance
- Therapeutic potential for anti-epileptic drugs targeting priming
- May affect dopaminergic synapse function
- Altered release properties in PD models
Munc13-2 is being explored as a therapeutic target:
- Phorbol ester derivatives: Activate via C1 domain
- Munc13-specific compounds in development
- AAV-mediated expression for synaptic restoration
- CRISPR approaches for variant correction
- CSF UNC13B levels as synaptic marker
- Synaptic vesicle protein panels
- Koch et al. (2000). Munc13-2 function in synaptic transmission
- Betz et al. (2001). Munc13 proteins as presynaptic organizers
- Rhee et al. (2002). Cluster formation of Munc13 proteins
- Jin et al. (2019). Munc13-1 in neurodegeneration
- He et al. (2018). Munc13-1 in Alzheimer's disease
- Brose et al. (1995). Munc13 homology domains
- Rosenmund et al. (2002). Munc13 priming function
- Augustin et al. (1999). Munc13-1 and synaptic vesicle priming